MARC JOSEPH GURWITH
Medical Practice in Los Altos, CA
License number
Pennsylvania MD031400E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Los Altos, CA 94022
Pennsylvania
Pennsylvania
Personal information
See more information about MARC JOSEPH GURWITH at radaris.comName
Address
Phone
13157 La Paloma Rd, Los Altos, CA 94022
13157 La Paloma Rd, Los Altos Hills, CA 94022
409 Central Ave, Menlo Park, CA 94025
13517 La Paloma Rd, Los Altos, CA 94022
2080 Fox Creek Rd, Berwyn, PA 19312
Professional information
Treatment Of Sle With Dehydroepiandrosterone
US Patent:
6552010, Apr 22, 2003
Filed:
Nov 10, 2000
Appl. No.:
09/710754
Inventors:
Kenneth E. Schwartz - San Mateo CA
Marc J. Gurwith - Los Altos CA
Marc J. Gurwith - Los Altos CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 3156
US Classification:
514177, 514170, 514171
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.
Dhea Composition And Method
US Patent:
7045513, May 16, 2006
Filed:
Mar 16, 2000
Appl. No.:
09/526802
Inventors:
Jagdish Parasrampuria - Bridgewater NJ, US
Maxine B. Yonker - Emerald Hills CA, US
Kenneth E. Schwartz - San Mateo CA, US
Marc J. Gurwith - Los Altos CA, US
Maxine B. Yonker - Emerald Hills CA, US
Kenneth E. Schwartz - San Mateo CA, US
Marc J. Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
A61K 31/56
US Classification:
514170, 514169, 514177, 514178, 514180
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.
Dhea Composition And Method
US Patent:
2006023, Oct 19, 2006
Filed:
Mar 21, 2006
Appl. No.:
11/387111
Inventors:
Jagdish Parasrampuria - Bedminster NJ, US
Maxine Yonker - Emerald Hills CA, US
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
Maxine Yonker - Emerald Hills CA, US
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
International Classification:
A61K 31/57
US Classification:
514177000
Abstract:
Disclosed are improved pharmaceutical formulations comprising dehydroepiandrosterone (DHEA), enriched in selected polymorphic forms, for therapeutic applications. In one embodiment, the formulation comprises, in solid form, DHEA, at least 85% of which is present as a single polymorph selected from the form I polymorph or the form II polymorph, and at least one pharmaceutical excipient. Methods for making and using such compositions are also disclosed.
Treatment Of Sle With Dehydroepiandrosterone
US Patent:
2003018, Sep 25, 2003
Filed:
Jan 8, 2003
Appl. No.:
10/340267
Inventors:
Kenneth Schwartz - San Mateo CA, US
Marc Gurwith - Los Altos CA, US
Marc Gurwith - Los Altos CA, US
Assignee:
Genelabs Technologies, Inc.
International Classification:
A61K031/57
US Classification:
514/178000
Abstract:
This invention provides a method of treating systemic lupus erythematosus (SLE) with (DHEA) and a related pharmaceutical product.